Keerti Bhamidipati

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 6

Top Topics

Oxide Nanoparticles

Binding Protein

Top Venues

Nanomedicine (London, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Gayathri Koula, Venu Yakati, Hari Krishnareddy Rachamalla, Keerti Bhamidipati, Muralidharan Kathirvel, Rajkumar Banerjee, Nagaprasad Puvvada
Integrin receptor-targeted, doxorubicin-loaded cerium oxide nanoparticles delivery to combat glioblastoma. Nanomedicine (London, England) 19 (15) (2024)
Gayathri Koula, Venu Yakati, Hari Krishnareddy Rachamalla, Keerti Bhamidipati, Muralidharan Kathirvel, Rajkumar Banerjee, Nagaprasad Puvvada
Integrin receptor-targeted, doxorubicin-loaded cerium oxide nanoparticles delivery to combat glioblastoma. Nanomedicine (London, England) 19 (15) (2024)
Gayathri Koula, Venu Yakati, Hari Krishnareddy Rachamalla, Keerti Bhamidipati, Muralidharan Kathirvel, Rajkumar Banerjee, Nagaprasad Puvvada
Integrin receptor-targeted, doxorubicin-loaded cerium oxide nanoparticles delivery to combat glioblastoma. Nanomedicine (London, England) 19 (15) (2024)
Gayathri Koula, Venu Yakati, Hari Krishnareddy Rachamalla, Keerti Bhamidipati, Muralidharan Kathirvel, Rajkumar Banerjee, Nagaprasad Puvvada
Integrin receptor-targeted, doxorubicin-loaded cerium oxide nanoparticles delivery to combat glioblastoma. Nanomedicine (London, England) (2024)
Gayathri Koula, Venu Yakati, Hari Krishnareddy Rachamalla, Keerti Bhamidipati, Muralidharan Kathirvel, Rajkumar Banerjee, Nagaprasad Puvvada
Integrin receptor-targeted, doxorubicin-loaded cerium oxide nanoparticles delivery to combat glioblastoma. Nanomedicine (London, England) 19 (15) (2024)
Gayathri Koula, Venu Yakati, Hari Krishnareddy Rachamalla, Keerti Bhamidipati, Muralidharan Kathirvel, Rajkumar Banerjee, Nagaprasad Puvvada
Integrin receptor-targeted, doxorubicin-loaded cerium oxide nanoparticles delivery to combat glioblastoma. Nanomedicine (London, England) 19 (15) (2024)